XML 105 R87.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes - Additional Information (Detail) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Sep. 26, 2014
Jun. 27, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Debt Instrument, Face Amount $ 128,250,000       $ 128,250,000      
Deferred Tax Liabilities, Deferred Expense, Deferred Financing Costs 10,300,000       $ 10,300,000      
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent         35.00% 35.00% 35.00%  
World Consolidated Loss Before Tax         $ 16,068,000 $ 21,795,000 $ 23,152,000  
Income Tax Benefit         $ 407,000 (24,453,000) 44,741,000  
Effective Income Tax Rate Reconciliation, Percent         3.00%      
Deferred Tax Assets, Valuation Allowance 64,545,000 $ 75,199,000     $ 64,545,000 75,199,000 38,644,000 $ 34,347,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3,100,000 300,000 $ 4,200,000 $ 24,500,000 3,100,000      
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent 15,900,000       15,900,000      
Decrease in balance as a result of a lapse of the applicable statues of limitations         900,000 9,500,000 1,300,000  
Net interest and penalties reduction related to unrecognized tax benefits         (31,000) (1,000,000) (5,600,000)  
Gross unrecognized tax benefits including interest and penalties 15,600,000       15,600,000      
Accrued potential interest related to unrecognized tax benefits 500,000 500,000     500,000 500,000    
Cumulative Undistributed Earnings of non-U.S. subsidiaries intended to be indefinitely reinvested $ 8,300,000       $ 8,300,000      
More Likely Than Not Threshold Recognition of Uncertain Tax Position 50.00%       50.00%      
California Franchise Tax Board [Member]                
Operating Loss Carryforwards $ 39,400,000       $ 39,400,000      
California Franchise Tax Board [Member] | Net Operating Loss due to Stock Options [Member]                
Tax credit carryovers 6,400,000       6,400,000      
Domestic Tax Authority [Member]                
Deferred Tax Assets, Valuation Allowance   $ 34,000,000       34,000,000    
2012 US Federal research tax credit [Member]                
Income Tax Benefit             2,400,000  
State [Member]                
Operating Loss Carryforwards 11,800,000       11,800,000      
Tax credit carryovers 31,300,000       $ 31,300,000      
Tax credit expiration         will not expire      
Foreign [Member]                
Operating Loss Carryforwards 81,100,000       $ 81,100,000      
Federal [Member]                
Operating Loss Carryforwards 11,800,000       11,800,000      
Tax credit carryovers 9,200,000       $ 9,200,000      
Year that federal tax credits expire         Jan. 01, 2031      
Federal [Member] | Net Operating Loss due to Stock Options [Member]                
Tax credit carryovers 1,400,000       $ 1,400,000      
Federal AMT [Member]                
Tax credit carryovers $ 2,700,000       $ 2,700,000      
Tax credit expiration         will not expire      
Switzerland [Member]                
Tax savings due to reduction in tax rate         $ 700,000 $ 700,000 $ 1,500,000  
Increase in diluted earnings per share         $ 0.008 $ 0.008 $ 0.014  
Benefits from a tax ruling         The Company’s operations in Switzerland are subject to a reduced tax rate under the Switzerland tax holiday which requires various thresholds of investment and employment in Switzerland.      
Additional period for renewal for investment and employment in foreign country         effective through the end of 2018      
Minimum [Member] | State [Member]                
Operating loss carryforwards, expiration date         Jan. 01, 2016      
Maximum [Member] | State [Member]                
Operating loss carryforwards, expiration date         Jan. 01, 2035      
Valuation Allowance of Deferred Tax Assets [Member] | Domestic Tax Authority [Member]                
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount           $ 29,000,000    
Federal NOL Carryback and R&D Credits [Member] | Domestic Tax Authority [Member]                
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount           (5,000,000)    
Israel Tax Authority [Member]                
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount         $ (900,000)      
Tax Year 2010 [Member] | Federal [Member]                
Income Tax Benefit           9,000,000    
Decrease in balance as a result of a lapse of the applicable statues of limitations           9,000,000    
Tax Year 2008 and 2009 [Member]                
Decrease in balance as a result of a lapse of the applicable statues of limitations             $ 39,000,000  
Tax Year 2008 and 2009 [Member] | Federal [Member]                
Decrease in balance as a result of a lapse of the applicable statues of limitations             39,000,000  
Tax Year 2011 [Member] | Federal [Member]                
Decrease in balance as a result of a lapse of the applicable statues of limitations         500,000      
Tax Year 2008 to 2011 [Member]                
Decrease in balance as a result of a lapse of the applicable statues of limitations         $ 200,000 $ 1,800,000 $ 7,500,000